Patients with low-grade upper tract urothelial carcinoma who achieved a complete response after receiving treatment with ...
cColorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia dMelbourne Bioinformatics, University of Melbourne, ...
Xencor's clear cell renal cell carcinoma treatment demonstrated evidence of anti-tumor activity in a phase 1 trial. The treatment XmAb819 had an acceptable safety profile that was generally well ...
SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- At 15:00 Beijing Time (09:00 am Berlin Time) on October 20, the "Global Launch Event for Iza-bren (EGFR×HER3 Bispecific ADC) Nasopharyngeal Carcinoma ...
Results from sub-study 03A of KEYMAKER-U03, an international, open-label, rolling-arm, phase I/II umbrella trial, spotlight the promise of pembrolizumab-based regimens combined with tyrosine kinase ...
State Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Sun Yat-sen University, Guangzhou 510275, China ...
Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States National High Magnetic Field Laboratory, FSU, Tallahassee, Florida 32310, ...
Division for Molecular Nutrition, Institute for Basic Medical Sciences, University of Oslo, Oslo, Norway The introduction of immune checkpoint inhibitors (ICIs) has revolutionized cancer therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback